Article
Licensed
Unlicensed
Requires Authentication
Pandemic influenza A (H1N1) 2009: the experience of the first six months
-
Jean Maritz
Published/Copyright:
December 22, 2009
Abstract
After a break of 41 years, 2009 saw the first influenza pandemic of the 21st century caused by a triple-reassortant influenza A (H1N1) virus. The current estimated case fatality rate is lower than that of previous influenza pandemics, but this may change as the pandemic evolves. Illness frequently occurs in previously healthy, young adults with a wide range of clinical presentations. The majority of circulating pandemic viruses remain susceptible to neuraminidase inhibitors, although all strains are intrinsically resistant to the adamantanes. Monovalent vaccines against the pandemic strain are available in both live attenuated and inactivated forms. This review aims to summarise important virological, epidemiological and clinical aspects of the pandemic influenza A (H1N1) virus for physicians and other clinical personnel.
Clin Chem Lab Med 2010;48:11–21.
Received: 2009-11-21
Accepted: 2009-11-23
Published Online: 2009-12-22
Published in Print: 2010-01-01
©2010 by Walter de Gruyter Berlin New York
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Editorials
- Rapid diagnosis of swine-origin influenza A (H1N1) virus (S-OIV): useful or hype?
- Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement
- Reviews
- Pandemic influenza A (H1N1) 2009: the experience of the first six months
- The role of anti-core antibody response in the detection of occult hepatitis B virus infection
- Opinion Papers
- Managing quality vs. measuring uncertainty in the medical laboratory
- Collective opinion paper on findings of the 2009 convocation of experts on quality control
- General Clinical Chemistry and Laboratory Medicine
- Diagnostic performance of rapid influenza antigen assays in patients infected with the new influenza A (H1N1) virus
- Achieving continuous improvement in laboratory organization through performance measurements: a seven-year experience
- Evaluation of errors in a clinical laboratory: a one-year experience
- Validation and Outcome Studies
- Analytical validation of serum bone alkaline phosphatase (BAP OSTASE) on Liaison
- Analytical performance of the serum free light chain assay
- A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage
- Plasma nitrite/nitrate concentrations in patients with schizophrenia
- Inverse relationship between serum high density lipoprotein and negative syndrome in antipsychotic-naive schizophrenia
- Reference Values and Biological Variations
- Biological variation of free plasma amino acids in healthy individuals
- Differences in serum potassium concentrations between Chinese, Indians and Malays
- Determination of median levels of the free β subunit of human chorionic gonadotropin in women from mainland China using a new time-resolved fluoroimmunoassay
- Age- and gender-specific reference ranges for serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations on the Immulite 2500: results of the Study of Health in Pomerania (SHIP)
- Cardiovascular Diseases
- Improvement of the cardiac marker N-terminal-pro brain natriuretic peptide through adjustment for renal function: a stratified multicenter trial
- Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness
- Letters to the Editor
- Serum total and free sialic acid in patients with chronic liver disease
- Measurement of nitrotyrosine in plasma by immunoassays is fraught with danger: commercial availability is no guarantee of analytical reliability
- Problems with the determination of nitrotyrosine in human plasma are not solved in a satisfactory way and conclusions from clinical trials need to be carefully revised
Articles in the same Issue
- Editorials
- Rapid diagnosis of swine-origin influenza A (H1N1) virus (S-OIV): useful or hype?
- Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement
- Reviews
- Pandemic influenza A (H1N1) 2009: the experience of the first six months
- The role of anti-core antibody response in the detection of occult hepatitis B virus infection
- Opinion Papers
- Managing quality vs. measuring uncertainty in the medical laboratory
- Collective opinion paper on findings of the 2009 convocation of experts on quality control
- General Clinical Chemistry and Laboratory Medicine
- Diagnostic performance of rapid influenza antigen assays in patients infected with the new influenza A (H1N1) virus
- Achieving continuous improvement in laboratory organization through performance measurements: a seven-year experience
- Evaluation of errors in a clinical laboratory: a one-year experience
- Validation and Outcome Studies
- Analytical validation of serum bone alkaline phosphatase (BAP OSTASE) on Liaison
- Analytical performance of the serum free light chain assay
- A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage
- Plasma nitrite/nitrate concentrations in patients with schizophrenia
- Inverse relationship between serum high density lipoprotein and negative syndrome in antipsychotic-naive schizophrenia
- Reference Values and Biological Variations
- Biological variation of free plasma amino acids in healthy individuals
- Differences in serum potassium concentrations between Chinese, Indians and Malays
- Determination of median levels of the free β subunit of human chorionic gonadotropin in women from mainland China using a new time-resolved fluoroimmunoassay
- Age- and gender-specific reference ranges for serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations on the Immulite 2500: results of the Study of Health in Pomerania (SHIP)
- Cardiovascular Diseases
- Improvement of the cardiac marker N-terminal-pro brain natriuretic peptide through adjustment for renal function: a stratified multicenter trial
- Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness
- Letters to the Editor
- Serum total and free sialic acid in patients with chronic liver disease
- Measurement of nitrotyrosine in plasma by immunoassays is fraught with danger: commercial availability is no guarantee of analytical reliability
- Problems with the determination of nitrotyrosine in human plasma are not solved in a satisfactory way and conclusions from clinical trials need to be carefully revised
